Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel?: A prospective, randomized study involving 630 biopsies

Journal of Clinical Gastroenterology

Volumn 45, Issue 3, 2011, Pages 228-233

  Whitson, Matthew J ^a   Dikman, Andrew E ^a   Von Althann, Caroline ^a   Sanyal, Shefali ^a   Desai, Jay C ^a   Bamji, Neville D ^a   Kornacki, Susan ^b   Harpaz, Noam ^c   Bodian, Carol A ^d   Cohen, Lawrence B ^a   Miller, Kenneth M ^a   Aisenberg, James ^a,b  

^a Division of Gastroenterology   (United States)

^b Department of Pathology ^*  (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d Ameripath Northeast Gastrointestinal Diagnostics   (United States)

Author keywords

antiplatelet; aspirin; bleeding; clopidogrel; endoscopic biopsy

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; CELECOXIB; CLOPIDOGREL; NAPROXEN; PLACEBO;

ADULT; AFRICAN AMERICAN; AGED; ANTICOAGULANT THERAPY; ARTICLE; ASIAN; BLOOD VESSEL DIAMETER; CAUCASIAN; DRUG EFFECT; ENTERIC COATED TABLET; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTRODUODENAL BIOPSY; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MUCOSA; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOADING DRUG DOSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK; SINGLE BLIND PROCEDURE; STOMACH HEMORRHAGE; STOMACH MUSCLE;

ADULT; ASPIRIN; BIOPSY; DUODENUM; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PYLORIC ANTRUM; RISK FACTORS; SINGLE-BLIND METHOD; TICLOPIDINE;

EID: 79951812589     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181eb5efd     Document Type: Article

References (33)

1. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
2. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420. (Pubitemid 35340537)
3. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol. 2007;50:e1-e157.
4. Khalique SC, Cheng-Lai A. Drug interaction between clopidogrel and proton pump inhibitors. Cardiol Rev. 2009;17: 198-200.
5. Ernst A, Eberhardt R, Wahidi M, et al. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest. 2006;129:734-737.
6. Ogoshi K, Kaneko E, Tada M et al. The management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc. 2005;47:2691-2695. [In Japanese].
7. Napoleon B, Boneu B, Maillard L, et al. Guidelines of the French Society for Digestive Endoscopy (SFED). Endoscopy. 2006;38:632-638.
8. Kimchi NA, Broide E, Scapa E, et al. Antiplatelet therapy and the risk of bleeding induced by gastrointestinal endoscopic procedures. Digestion. 2007;75:36-45.
9. Eisen GM, Baron TH, Dominitz JA, et al. Guidelines on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc. 2002;55:775-779.
10. Zuckerman MS, Hirota WK, Adler DG, et al. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet therapy for endoscopic procedures. Gastrointest Endosc. 2005;61:189-194. (Pubitemid 40261064)
11. Veitch AM, Baglin TP, Gershlick AH, et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut. 2008;57: 1322-1329.
12. Anderson MA. The New ASGE Guidelines. Sp587: Presented at Digestive Disease Week Conference, Chicago, IL, June 2, 2009.
13. Lee SY, Tang SJ, Rockey DC, et al. Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West. Gastrointest Endosc. 2008;67:1076-1081.
14. Fujishiro M, Oda I, Yamamoto Y, et al. Multi-center survey regarding the management of anticoagulation and antiplatelet therapy for endoscopic procedures in Japan. J Gastroenterol Hepatol. 2009;24:214-218.
15. Mosler P, Mergener K, Denzer U, et al. Current practice in managing patients on anticoagulants and/or antiplatelet agents around the time of gastrointestinal endoscopy-a nation-wide survey in Germany. Z Gastroenterol. 2004;42: 1289-1293. (Pubitemid 39647811)
16. Kadakia SC, Angueira CE, Ward JA, et al. Gastrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: survey of ASGE members. Gastrointest Endosc. 1996;44:309-316. (Pubitemid 26318334)
17. Dikman A, Sanyal S, von Althann C, et al. A randomized, placebo-controlled study of the effects of naproxen, aspirin, celecoxib or clopidogrel on gastroduodenal mucosal healing. Aliment Pharmacol Ther. 2009;29:781-791.
18. Savcic M, Hauert J, Bachmann F, et al. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost. 1999;25(suppl 2): 15-19. (Pubitemid 29350286)
19. Hudson N, Balsitis M, Everitt S, et al. Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. Gut. 1995;37:191-194.
20. Yao M, von Rosenvinge EC, Groden C, et al. Multiple endoscopic biopsies in research subjects: safety results from a National Institute of Health series. Gastrointest Endosc. 2009;69:906-913.
21. Siersma PD. Endoscopic research biopsies in human subjects: is it safe enough? Gastrointest Endosc. 2009;69:911-913.
22. Fork FT, Lafolie P, Toth E, et al. Gastroduodenal tolerance of 75mg of clopidogrel versus 325mg aspirin in healthy volunteers. Scand J Gastroenterol. 2000;35:464-469. (Pubitemid 30354084)
23. Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352:238-244. (Pubitemid 40110812)
24. Tan VP, Yan BP, Kiernana TJ, et al. Risk and management of upper gastrointestinal bleeding associated with prolonged dual anti-platelet therapy after percutaneous coronary intervention. Cardiovasc Revasc Med. 2009;10:36-44.
25. Ma L, Elliott SN, Cirino G, et al. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A. 2001;98:6470-6475. (Pubitemid 32488261)
26. O'Laughlin JC, Hoftiezer JW, Mahoney JP, et al. Does aspirin prolong bleeding from gastric biopsies in man? Gastrointest Endosc. 1981;27:1-5. (Pubitemid 11137277)
27. Yamamoto T, Ebato T, Mishina Y, et al. Low-dose aspirin prolongs bleeding time after endoscopic biopsy of the gastric antrum in Japanese patients. Abstract #M1380: Presented at Digestive Disease Week Conference; Chicago, IL; June 1, 2009.
28. Mak KH, Bhatt DL, Shao M, et al. Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (CHARISMA) study. Am Heart J. 2009;157:658-665.
29. Sieg A, Hachmoeller-Eisenbach U, Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. Gastrointest Endosc. 2000;51:37-41.
30. Komatsu T, Tamai Y, Takami H, et al. Study for determination of the optimal cessation period of therapy with antiplatelet agents prior to invasive endoscopic procedures. J Gastroenterol. 2005;40:698-707. (Pubitemid 41349081)
31. Guglielmi A, Ruzzenente A, Sandri M, et al. Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy. 2002;34:778-786.
32. Chung IK, Kim EJ, Lee MS, et al. Endoscopic factors predisposing to rebleeding following endoscopic hemostasis in bleeding peptic ulcers. Endoscopy. 2001;33:969-975. (Pubitemid 33034735)
33. Schoen FJ. Blood vessels. In: Kumar V, Abbas A, Fausto N, eds. Pathologic Basis of Disease. 7th ed. Philadelphia: Elsevier Saunders; 2005:511-554.